A detailed history of Everence Capital Management Inc transactions in Vericel Corp stock. As of the latest transaction made, Everence Capital Management Inc holds 6,960 shares of VCEL stock, worth $394,562. This represents 0.02% of its overall portfolio holdings.

Number of Shares
6,960
Previous 6,960 -0.0%
Holding current value
$394,562
Previous $319,000 7.84%
% of portfolio
0.02%
Previous 0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 16, 2023

SELL
$31.69 - $39.25 $58,943 - $73,005
-1,860 Reduced 21.09%
6,960 $233,000
Q3 2021

Oct 21, 2021

BUY
$46.35 - $59.75 $108,459 - $139,815
2,340 Added 36.11%
8,820 $430,000
Q1 2021

Apr 06, 2021

BUY
$30.93 - $59.48 $200,426 - $385,430
6,480 New
6,480 $360,000

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.67B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Everence Capital Management Inc Portfolio

Follow Everence Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Everence Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Everence Capital Management Inc with notifications on news.